These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 32035969

  • 1. Small scale design of experiment investigation of equilibrium solubility in simulated fasted and fed intestinal fluid.
    McPherson S, Perrier J, Dunn C, Khadra I, Davidson S, Ainousah B, Wilson CG, Halbert G.
    Eur J Pharm Biopharm; 2020 May; 150():14-23. PubMed ID: 32035969
    [Abstract] [Full Text] [Related]

  • 2. Statistical investigation of simulated fed intestinal media composition on the equilibrium solubility of oral drugs.
    Zhou Z, Dunn C, Khadra I, Wilson CG, Halbert GW.
    Eur J Pharm Sci; 2017 Mar 01; 99():95-104. PubMed ID: 27940083
    [Abstract] [Full Text] [Related]

  • 3. Statistical investigation of the full concentration range of fasted and fed simulated intestinal fluid on the equilibrium solubility of oral drugs.
    Perrier J, Zhou Z, Dunn C, Khadra I, Wilson CG, Halbert G.
    Eur J Pharm Sci; 2018 Jan 01; 111():247-256. PubMed ID: 28987539
    [Abstract] [Full Text] [Related]

  • 4. Statistical investigation of simulated intestinal fluid composition on the equilibrium solubility of biopharmaceutics classification system class II drugs.
    Khadra I, Zhou Z, Dunn C, Wilson CG, Halbert G.
    Eur J Pharm Sci; 2015 Jan 25; 67():65-75. PubMed ID: 25444845
    [Abstract] [Full Text] [Related]

  • 5. Small scale in vitro method to determine a bioequivalent equilibrium solubility range for fasted human intestinal fluid.
    Abuhassan Q, Khadra I, Pyper K, Halbert GW.
    Eur J Pharm Biopharm; 2021 Nov 25; 168():90-96. PubMed ID: 34419602
    [Abstract] [Full Text] [Related]

  • 6. Small scale in vitro method to determine a potential bioequivalent equilibrium solubility range for fed human intestinal fluid.
    Inês Silva M, Khadra I, Pyper K, Halbert GW.
    Eur J Pharm Biopharm; 2022 Aug 25; 177():126-134. PubMed ID: 35718078
    [Abstract] [Full Text] [Related]

  • 7. Dual Level Statistical Investigation of Equilibrium Solubility in Simulated Fasted and Fed Intestinal Fluid.
    Ainousah BE, Perrier J, Dunn C, Khadra I, Wilson CG, Halbert G.
    Mol Pharm; 2017 Dec 04; 14(12):4170-4180. PubMed ID: 29072917
    [Abstract] [Full Text] [Related]

  • 8. Fasted and fed state human duodenal fluids: Characterization, drug solubility, and comparison to simulated fluids and with human bioavailability.
    Dahlgren D, Venczel M, Ridoux JP, Skjöld C, Müllertz A, Holm R, Augustijns P, Hellström PM, Lennernäs H.
    Eur J Pharm Biopharm; 2021 Jun 04; 163():240-251. PubMed ID: 33872761
    [Abstract] [Full Text] [Related]

  • 9. Multidimensional analysis of human intestinal fluid composition.
    Pyper K, Brouwers J, Augustijns P, Khadra I, Dunn C, Wilson CG, Halbert GW.
    Eur J Pharm Biopharm; 2020 Aug 04; 153():226-240. PubMed ID: 32585351
    [Abstract] [Full Text] [Related]

  • 10. Effect of composition of simulated intestinal media on the solubility of poorly soluble compounds investigated by design of experiments.
    Madsen CM, Feng KI, Leithead A, Canfield N, Jørgensen SA, Müllertz A, Rades T.
    Eur J Pharm Sci; 2018 Jan 01; 111():311-319. PubMed ID: 28986196
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intestinal drug solubility estimation based on simulated intestinal fluids: comparison with solubility in human intestinal fluids.
    Clarysse S, Brouwers J, Tack J, Annaert P, Augustijns P.
    Eur J Pharm Sci; 2011 Jul 17; 43(4):260-9. PubMed ID: 21570465
    [Abstract] [Full Text] [Related]

  • 13. Fasted intestinal solubility limits and distributions applied to the biopharmaceutics and developability classification systems.
    Abuhassan Q, Khadra I, Pyper K, Augustijns P, Brouwers J, Halbert GW.
    Eur J Pharm Biopharm; 2022 Jan 17; 170():160-169. PubMed ID: 34923138
    [Abstract] [Full Text] [Related]

  • 14. Advances in the design of fasted state simulating intestinal fluids: FaSSIF-V3.
    Fuchs A, Leigh M, Kloefer B, Dressman JB.
    Eur J Pharm Biopharm; 2015 Aug 17; 94():229-40. PubMed ID: 26032292
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A review of drug solubility in human intestinal fluids: implications for the prediction of oral absorption.
    Augustijns P, Wuyts B, Hens B, Annaert P, Butler J, Brouwers J.
    Eur J Pharm Sci; 2014 Jun 16; 57():322-32. PubMed ID: 23994640
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Structured solubility behaviour in bioequivalent fasted simulated intestinal fluids.
    Abuhassan Q, Khadra I, Pyper K, Augustijns P, Brouwers J, Halbert GW.
    Eur J Pharm Biopharm; 2022 Jul 16; 176():108-121. PubMed ID: 35605926
    [Abstract] [Full Text] [Related]

  • 20. Fed intestinal solubility limits and distributions applied to the Developability classification system.
    Silva MI, Khadra I, Pyper K, Halbert GW.
    Eur J Pharm Biopharm; 2023 May 16; 186():74-84. PubMed ID: 36934829
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.